Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing the effect of probiotic and fluconazole in treatment and recurrence of vaginal candidiasis
IRCT20110826007418N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of fluconazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Tabriz University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
fluconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on IRCT20110826007418N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110826007418N5.